---
title: "Inovio 制药 (INO.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/INO.US/norm.md"
symbol: "INO.US"
name: "Inovio 制药"
parent: "https://longbridge.com/zh-CN/quote/INO.US.md"
datetime: "2026-05-19T16:12:51.711Z"
locales:
  - [en](https://longbridge.com/en/quote/INO.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INO.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INO.US/norm.md)
---

# Inovio 制药 (INO.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -0.2848 | 0.0607 | -0.8721 | -0.6057 | -0.5100 |
| ROE | -522.02% | 183.92% | -1748.95% | -235.84% | -131.57% |
| 营业收入 | - | 0.0000 | - | - | 65343.00 |
| 净利润 | -19.68M | 3.76M | -45.50M | -23.52M | -19.69M |
| 营业利润 | -21.95M | -17.48M | -21.21M | -23.08M | -25.05M |
| 毛利率 | - | - | - | - | -24525.29% |
| 净利率 | - | - | - | - | -30140.48% |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 49.78M | 74.31M | 69.39M | 68.24M | 87.27M |
| 权益乘数 | 8.20 | 3.08 | -8.99 | 2.39 | 1.70 |
| 每股净资产 | 0.0738 | 0.3492 | -0.1441 | 0.7770 | 1.40 |
| 资产周转率 | 0.0000 | 0.0007 | 0.0021 | 0.0018 | 0.0026 |
| 现金及短投 | 37.68M | 58.51M | 50.80M | 47.55M | 68.36M |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 8.33M | 9.07M | 9.70M | 10.45M | 11.09M |
| 净债务 | -28.99M | -49.14M | -40.78M | -36.89M | -57.09M |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -21.59M | -19.37M | -21.57M | -20.81M | -26.87M |
| 投资现金流 | 2.64M | -58189.00 | 8.87M | 5.28M | -51753.00 |
| 融资现金流 | 953790.00 | 27.13M | 24.92M | -34777.00 | 1.03M |
| 自由现金流 | -17.95M | -34.00M | 26.97M | -10.21M | -21.47M |
| 现金流充裕率 | - | -15199.26% | -31748.61% | -67285.35% | -45263.04% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | - | -127444.00 | -67951.00 | -30930.00 | -59373.00 |